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This article discusses the availability and completeness of medical data on workers from the AREVA NC 
Pierrelatte nuclear plant and their possible use in epidemiological research on cardiovascular and metabolic 
disorders related to internal exposure to uranium. We created a computer database from files on 394 eligible 
workers included in an ongoing nested case-control study from a larger cohort of 2897 French nuclear 
workers. For each worker, we collected records of previous employment, job positions, job descriptions, 
medical visits, and blood test results from medical history. The dataset counts 9,471 medical examinations 
and 12,735 blood test results. For almost all of the parameters relevant for research on cardiovascular risk, 
data completeness and availability is over 90 %, but it varies with time and improves in the latest time 
period. In the absence of biobanks, collecting and computerising available good-quality occupational 
medicine archive data constitutes a valuable alternative for epidemiological and aetiological research in 
occupational health. Biobanks rarely contain biological samples over an entire worker’s carrier and medical 
data from nuclear industry archives might make up for unavailable biomarkers that could provide information 
on cardiovascular and metabolic diseases.
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Studies able to properly assess the risk of internal 
contamination with radioactive compounds are scarce. 
This can partly be explained by the difficulty to 
reliably reconstruct the received internal dose or by 
the need of a long and robust follow-up to be able to 
do that. In France, the population of nuclear workers 
from AREVA NC’s Pierrelatte facility appears to be 
interesting in this respect. The main activities at this 
plant involved uranium hexafluoride (UF6) enrichment 
between 1959 and 1990 and the chemical conversion 
of uranium in the 1980s. The plant produced uranium 
compounds enriched in 235U to different degrees from 
natural uranium ore but also reprocessed uranium from 
spent fuel turned into stable compounds for storage. 
Some workers were therefore potentially exposed to 
inhalation of uranium particles and other industrial 
chemicals. A retrospective pilot study in 2005 aimed 
at examining the effects of long-term, low-dose 
exposure to different uranium compounds in a cohort 
of plant workers (1). In the 2010 extension (2), the 
cohort totalled 2,897 workers who remained at the 
plant for at least six months between 1 January 1968 
and 31 December 2006. At first, the available 
information regarding these workers could not be used 
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to reconstruct individual occupational exposure to 
uranium. For this reason, an epidemiological approach 
consisting of a semi-quantitative exposure assessment 
was developed in 2007 (3) and later a specific job 
exposure matrix (JEM) was designed to obtain a 
retrospective estimate of cumulative exposure to 
different uranium compounds and other pollutants (4). 
On the basis of this exposure assessment a relationship 
was established for lung and hematopoietic cancer (5).
Over the last decade, a potential risk of 
cardiovascular diseases associated with ionising 
radiation has become a major issue (6-11) but with 
inconsistent results in low-dose exposure studies (12, 
13). Therefore, possible cardiovascular effects of 
internal uranium contamination were also studied in 
the Pierrelatte workers cohort (2). The results suggest 
that exposure to slowly soluble uranium compounds, 
notably reprocessed uranium compounds, may 
increase the risk of mortality from circulatory system 
diseases. The main limitations to analysing this cohort 
with specific internal exposure was the absence of 
individual biological and lifestyle data, especially 
about the known cardiovascular risk factors as defined 
by the Framingham study (14-16) or the international 
INTERHEART study (17, 18). Another limitation was 
the absence of organ-specific doses from uranium 
exposure.
Occupational medicine (OM) in French nuclear 
industry began simultaneously with uranium 
processing at the beginning of the 1950s. The principal 
aim of occupational physicians was to detect workers’ 
health problems at the time of employment and to 
monitor their health status over the entire professional 
life. In this new domain, the first guidelines were 
mainly based on the experience of physicians and 
medical research pioneers. Thanks to national 
regulations requiring that occupational medical 
records are archived, most cardiovascular risk 
parameters are still kept on record, covering a period 
from 1958 to the present.
We studied these OM archives and collected the 
basic anthropometric data (height, weight), blood 
pressure (systolic and diastolic), and blood tests for 
all the monitored workers. Our intention was to test 
the hypothesis that low-dose ionising radiation 
increases the risk of cardiovascular diseases, taking 
into account these individual parameters. For this 
reason we have launched a nested case-control study 
that includes 394 workers (111 cases, up to 5 controls 
per case) from the cohort. The study is still under way.
In this preliminary report, however, we focus on 
the dataset collected in the above study in order to see 
whether the collected data could be useful for an 
epidemiological study or an aetiological research and 
to discuss other potential uses and limitations of OM 
records such as this. We analysed the type, quality, 
and variations in clinical and recording practice over 
time.
MEDICAL DATA COLLECTION AND 
ANALYSIS
Study population
The data presented here are related to a subsample 
of 394 eligible workers from the cohort of 2,897 
workers employed at the AREVA NC Pierrelatte plant 
for at least six months between 1960 and 31 December 
2006. The larger cohort was analysed for cancer and 
cardiovascular outcomes with unexpected results (2, 
5) that called for further investigation. We collected 
additional data on potential risk factors for 
cardiovascular and metabolic diseases in order to 
establish their relationship with long-term exposure 
to low-dose uranium. In the choice of data to collect 
we primarily relied on the INTERHEART study (17, 
18). The subsample was obtained by matching 111 
cases of death from cardiovascular diseases (CVD) 
with controls according to sex, calendar period, five-
year age classes, and socio-economic status at hire 
(clerical workers, engineering / management or 
technician) to account for potential confounding, 
especially regarding uranium exposure data which 
were available from the cohort study (19). Each case 
was matched to up to five controls whenever possible. 
One control could match more than one case, if the 
matching criteria were met. People who later died but 
at a certain earlier point met these matching criteria 
were also used as controls. To obtain the sample of 
controls who were alive at the time of death of the 
case we used an incidence density sampling method 
(20). Seventy cases were matched to five controls, five 
to four controls, another five to three controls, nine to 
two controls, and 13 cases to one control. No match 
was found for nine cases, including two women cases 
and cases with unmatchable combination of age and 
socio-economic status at hire.
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Monitoring time frame and database creation
The data analysed here have been collected from 
OM monitoring records that span from 1959 to 2011, 
starting from workers’ screening at hire to the last 
follow-up. Medical examination by occupational 
physicians was annual, but some of the workers 
received bi- or trimestral check-up, depending on 
exposure conditions.
Most of the paper archives were found in the 
Occupational Medicine Department (OMD) of the 
AREVA NC Pierrelatte plant. When the last 
employment was in another plant of the AREVA 
Group, we were able to track down the medical file 
of the worker. The files matching our population set 
were coded by ID numbers.
For each worker we reconstructed a computer file 
containing full medical records by manually entering 
all data from the paper archive. All results had been 
converted to the more recent unit. The data were then 
split into 14 interrelated database tables: identification 
(including the first and last day of work at the plant, 
height, and full medical history); previous 
employments; job positions; job description; smoking 
(describing changes in tobacco consumption); 
pulmonary radiographs; external dosimetry; radio 
toxicological analyses results; accidental 
contaminations; number and causes of sick leave; 
capability certificates; electrocardiogram reports, 
medical examination findings, and blood tests. The 
last two tables were the subject of our analysis, as 
the parameters contained in them provide key 
information about CVD risks. The medical 
examination table includes data about weight, systolic 
and diastolic blood pressure, pulse, and cardiovascular, 
cancer, or other disease observations registered at each 
visit. The blood tests include standard haematological 
parameters (erythrocytes, leucocytes, haematocrit, 
basophils, eosinophils, lymphocytes, monocytes, 
and platelets) and available metabolic parameters 
(total cholesterol, high-density lipoprotein (HDL), 
low-density lipoprotein (LDL), urea, blood sugar, 
triglycerides, creatinine, urea and uric acid, and 
gamma-glutamyl-transpeptidases (GGT)).
For all workers we computed body mass index 
(BMI) based on the standard formula:
For the body surface area (BSA) we used the 
Dubois and Dubois formula (21):
BSA=0.20247*Height(m)0.725 *weight(kg)0.425
Data quality and analysis
The quality of data in the database tables was 
assessed primarily by checking maximum and 
minimum values to identify and correct extreme 
values. Then the data of 30 randomly selected paper 
files were systematically reviewed to identify 
potential mistakes. All database values were 
compared to paper files. Of nearly 1,700 database 
values, only nineteen were wrong, indicating an 
error rate of about 1 %. These errors were further 
checked by comparing them with individual 
parameter means and medians and normal ranges.
For all parameters of interest we calculated two 
main indicators: availability and completeness. 
Availability is the percentage of workers with at 
least one recorded value and completeness is the 
number of recorded medical examination or blood 
test results divided by the total number of workers.
RESULTS AND DISCUSSION
The main characteristics of the collected data are 
given in Table 1. Among the workers, 12 are still 
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Table 1 Main characteristics of collected data at the AREVA 
NC Pierrelatte uranium processing plant
Characteristics N
Population 394 (100 %)
Potentially exposed to uranium 
compounds 330 (84 %)
Female workers 9 (2 %)
Mean age at recruitment (y) (min-
max) 35 (20-57)
Median age at recruitment (y) 35.3
Mean OM* follow-up (y) (min-max) 21 (1-37)
Median OM* follow-up (y) 20.2
Total number of medical 
examinations 9471
Mean number of medical 
examinations per worker (min-max) 25 (1-57)
Median number of medical 
examination 22
Total number of results of blood test 
from medical history 12735
Mean number of results of blood 
test from medical history per worker 
(min-max)
32 (1-93)
Median number of results of blood 
test from medical history per worker 31
*OM=Occupational Medicine
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employed. The mean time between the last medical 
examination and the occurrence of death by 
cardiovascular disease is 11.61 years (±8 years). 
Workers with more than 10 years since the last medical 
examination make 56.8 % of the population.
Over the monitoring period, 9,471 medical 
examinations were performed and 12,735 blood test 
results obtained (Table 2). In terms of the means this 
translates to 25 medical examinations and 35 blood 
test results per person. The data show that 187 
(47.10%) had 20-29 medical examinations and 286 
(72.6%) at least 20 medical examinations. Only 34 
(8.2%) workers have less than 20 blood test results 
recorded.
This database clearly shows that changes in the 
cardiovascular system (e.g. systolic and diastolic 
pressure) of the workers had been carefully monitored. 
The number of medical examinations and blood tests 
is sufficient to provide reliable information about a 
relevant parameter for further epidemiological or 
aetiological research.
Table 3 shows the completeness and the availability 
of specific variables of interest. It ranged between 
1.2 % for HDL cholesterol and 99.8 % for granulocytes, 
Table 2 Anthropometric and biomedical data collected at the AREVA NC Pierrelatte uranium processing plant for 394 workers
Variables Unit N of measurements Range
Medical examination (N=9471)
Height cm 394i 152-190
Weight kg 9263 44-116
Systolic blood pressure mmHg 9379 90-290
Diastolic blood pressure mmHg 9375 40-170
Body Mass Index kg m-2 9256 16.6-37.4
Body Surface Area m2 9206 1.4-2.4
Blood tests from medical history (N=12735)
Erythrocytes count million mm-3 12696 4.1-6.0
Haemoglobin g dL-1 12480 3.64-17.8
Haematocrit % 11639 33.3-62.0
Mean corpuscular volume m3 11932 32.2-199.0
Leucocytes n mm-3 12696 4000-25600
Lymphocytes % 12709 0-78
Monocytes % 12709 0-56
Thrombocytes n mm-3 2445 91-685
Neutrophil granulocytes % 12709 19-88
Eosinophil granulocytes % 12709 0-36
Basophil granulocytes % 12709 0-7
Metabolic parameters
Total cholesterol g L-1 7284 1.0-5.1
LDLii cholesterol g L-1 993 0.2-2.4
HDLiii cholesterol g L-1 153 0.4-3.6
Glycaemia g L-1 7169 0.1-3.3
Triglycerides g L-1 1273 0.3-12.5
Creatinine mg L-1 1623 0.2-19.0
GGT IU L-1 1452 2-112.5
Urea g L-1 11385 0.1-0.47
Uric acid mg L-1 7169 0-140
iHeight was collected once for each worker
iiLDL= low density lipoproteins
iiiHDL=high density lipoproteins
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lymphocytes, monocytes, and height. The availability 
of specific variables ranged from 8.3 % for HDL 
cholesterol to 99.8 % for height. The high completeness 
of blood count data provides reliable information for 
investigating possible effects of exposure to ionising 
radiation and uranium on blood count.
Change of recording practice over time
Workers hired before 1970 make 91 % of our 
population. For them, the completeness of almost 
every parameter of medical examination or blood test 
is ≥90%. The exceptions are HDL and LDL cholesterol, 
triglyceride, GGT, and creatinine. Until the 1960s only 
high cholesterol values were recorded. Routine 
recording started only after 1973, with the first major 
publications on total cholesterol as a cardiovascular 
risk factor (22-25). For workers hired later than 1970 
the completeness rose highly, except, once again for 
HDL cholesterol (Figure 1).
The choice of parameters and their biological 
relevance
The sample analysed in this study provided highly 
complete and available data on the risk factors for 
acute myocardial infarction, including the history of 
hypertension (almost 99 % completeness for systolic 
Table 3 Completeness and availability of worker follow-up data from medical examinations and blood tests
Variables Completeness of data*
Availability of 
workers' data**
Year of first and 
last recorded value
Medical visits
Height 99.8 % 99.8 % 1959-2011
Weight 97.7 % 99.2 % 1959-2011
Diastolic blood pressure 99.0 % 99.2 % 1959-2011
Systolic blood pressure 98.9 % 99.2 % 1959-2011
Pulse 90.4 % 99.2 % 1959-2011
BMI/BSA 97.6 % 99.2 % 1959-2011
Results of blood test from medical history
Erythrocytes 99.7 % 99.2 % 1959-2011
Haemoglobin 98.0 % 99.2 % 1959-2011
Haematocrits 91.4 % 98.7 % 1959-2011
Mean corpuscular volume 93.7 % 99.2 % 1959-2011
Leucocytes 99.7 % 99.2 % 1959-2011
Lymphocytes 99.8 % 99.2 % 1959-2011
Monocytes 99.8 % 99.2 % 1959-2011
Thrombocytes 19.2 % 92.0 % 1959-2011
Neutrophil granulocytes 99.8 % 99.2 % 1959-2011
Eosinophil granulocytes 99.8 % 99.2 % 1959-2011
Basophil granulocytes 99.8 % 99.2 % 1959-2011
Metabolic parameters
Total cholesterol 57.2 % 98.5 % 1961-2011
LDL cholesterol 7.8 % 30.0 % 1985-2011
HDL cholesterol 1.2 % 8.3 % 1968-2011
Glycaemia 56.3 % 98.5 % 1959-2011
Triglycerides 10.0 % 42.3 % 1969-2011
Urea 89.4 % 99.0 % 1959-2011
Creatinine 12.7 % 69.3 % 1966-2011
GGT 11.4 % 40.8 % 1963-2011
Uric acid 56.3 % 98.5 % 1965-2011
*Percentage calculated as the number of collected values over the number of medical examination or results of blood test from 
the medical history for each workers, divided by the total number of workers with collected values
**Percentage of workers with at least one value
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and diastolic pressure), abdominal obesity (by 
calculating BMI/BSA), total cholesterol, and diabetes 
(using blood sugar as an indicator). About 50 % of the 
workers had both blood sugar and cholesterol 
measured. Records on psychosocial risk factors like 
stress and hard physical activity at work or physical 
activity in free time were too scarce or imprecise to 
use as required by the INTERHEART study (17).
Since the follow-up was no more compulsory after 
retirement, few data cover that period. However, 
because most workers were exposed to chronic low-
rate exposure to ionising radiation and uranium rather 
than acute, high-rate accidental exposure, potential 
health effects would be mainly long-term, evolving 
from light to moderate biological and physiological 
changes that could lead to clinically detectable 
symptoms or a disease once they become irreversible. 
Therefore, it should be possible to identify any 
changes in parameters from the data collected during 
employment and investigate how these changes may 
influence the occurrence of cardiovascular disease 
from a mechanistic point of view.
One major advantage of our approach is that for 
most of the parameters it can provide not only one 
value per individual, but the whole variation over time. 
For example, every worker had a mean of 23 systolic 
blood pressure measurements over the median follow-
up of 20 years.
The Framingham Cardiac Risk Score (22) is a 
well-known tool to predict 10-year cardiovascular 
risks for an individual. It requires seven variables to 
calculate the risk: sex, age, total cholesterol, HDL 
cholesterol, systolic and diastolic blood pressure, 
diabetic status, and smoking status. The availability 
of data for all the required parameters in our dataset 
is good, with the notable exception of HDL cholesterol 
(which is available for only 33 workers). The diabetic 
status can be determined on the basis of blood sugar 
levels. Smoking records are not uniform (detailed 
information on tobacco consumption and duration of 
smoking is only partly known) and can only be 
analysed as a binary variable across the sample.
Considering that blood count parameters in our 
sample have almost 100 % completeness and 
availability over time, it would be relatively easy to 
evaluate the effects of low-dose ionising radiation on 
blood counts (23, 24). Diastolic and systolic blood 
pressure can also be analysed in relation to internal 
uranium dose received before retirement. With the 
added benefit of blood counts and medical examination 
parameters, robust studies are possible.
In contrast, the majority of metabolic parameters 
reached 50 % completeness in the 1980’s and could 
therefore be considered only with great caution and 
an extension of the workers’ follow-up.
The only important variables with low availability 
in our dataset are creatinine and HDL cholesterol. 
Creatinine is a marker of renal function, fundamental 
in uranium internal contamination, while HDL is an 
important element of the Framingham score.
Potential use in the upcoming nested case-control 
study
The collected data will be used in the upcoming 
nested case-control study as co-variables in addition 
to the main exposure variables (e.g. exposure to 
ionising radiation and uranium compounds) to 
investigate how they could have affected the results 
of the previous cohort study by Guseva Canu et al. 
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Figure 1 Completeness of medical examination and blood test parameters data by decades
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(2). In that study, the effects of exposure to uranium 
compounds on cardiovascular mortality were assessed 
without taking into account the known cardiovascular 
risk factors, as they were not available at the time. 
Therefore, the collected variables will primarily be 
analysed as possible confounding or modifying factors 
using a conditional logistic model. These analyses 
should be able to handle time-dependent covariates 
because of the longitudinal changes in blood tests and 
anthropometry over time.
Potential for broader use
The large set of collected haematological data will 
allow us to address the hypotheses on the association 
between haematological parameters/hypertension and 
internal uranium contamination. For instance, Wagner 
et al. (25) found that exposed women ran a higher risk 
of elevated systolic pressure.
The use of longitudinal data makes it possible to 
evaluate correlations within and between workers 
using generalised estimating equations (26). Thus, in 
addition to assessing the modifying or confounding 
effects on cardiovascular mortality, OM data can also 
be used independently, as an intermediate health 
outcome to assess the effect of uranium exposure on 
health parameters such as blood pressure.
In that sense, OM data could also be used for 
aetiological research. Kathren et al. (27, 28) have 
already pointed to acute internal exposure to uranium 
compounds as the possible cause of kidney disease 
(27, 28). Low-dose radiation effects are less consistent 
in the literature, but some of the evidence calls for 
further studies (29, 30). In fact, the archived files we 
reviewed do refer to adverse renal effects, and 
consistently so to renal colic. We believe that data on 
creatinine will be useful for pending studies of the 
effects of radiation on the renal function in the plant 
workers.
Furthermore, the OM data appear to be an 
important source of information for retrospective 
studies. A longitudinal follow-up of workers makes 
possible the use of various epidemiological and 
statistical models to retrospectively assess exposure 
risk and build a robust prospective cohort. If no 
specific sampling of biological material is available, 
the use of routinely collected OM data may be justified 
prior to further research. A major limitation to the use 
of OM data for epidemiological research are the 
missing or incorrect values in the database. However, 
this issue can be addressed with frequentist (31) or 
Bayesian (32) or other methods (33). If there is no 
pattern to missing data, this could be resolved by 
careful data management, but if the errors are 
systematic, Bayesian method could help to fill them 
in.
As biobanks are very difficult to set up in France 
for ethical and economic reasons, the electronic 
storage of half a century of archived OM data on 
nuclear workers is a cost-effective alternative. Such 
data are generally directly available, accurate, and free 
of recall bias. Most are systematic (annual) biological 
measurements that span the worker’s career and follow 
strict medical surveillance procedures. Moreover, 
biobanks rarely keep biological samples for an entire 
career.
Finally, since the OM follow-up provides 
epidemiologists with longitudinal data, it also provides 
an insight into the causal relationship between 
exposure to ionising radiation and symptomatic 
coronary artery disease through the effects of radiation 
on leucocyte and monocyte counts (34). The use of 
data already obtained by health monitoring should 
efficiently complement molecular epidemiology 
studies. These data could be used as a reference for 
additional data collected after retirement. Furthermore, 
systematic blood records for each worker make it 
easier to collect additional samples to analyse new 
biomarkers (DNA, mutations, epigenetic markers, 
etc…).
Overall, the recording practices at the AREVA NC 
Pierrelatte facility provide a reliable basis for 
epidemiological studies, especially regarding blood 
counts and medical examination parameters. The 
completeness and availability of the data are relatively 
high for known major cardiovascular risk factors. The 
major strength of our subsample database is that it can 
reduce/control potential confounding and effect-
modifying factors. Data on the full cohort will allow 
an even more precise evaluation of radiation effects 
by taking into account the parameters that can affect 
the circulatory system.
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Sažetak
Polustoljetni arhiv odjela za medicinu rada francuske nuklearne elektrane - prašnjavo skladište ili 
zlatni rudnik za epidemiološka istraživanja?
U ovome se članku raspravlja o dostupnosti i potpunosti medicinskih podataka o radnicima iz nuklearne 
elektrane AREVA NC Pierrelatte te o njihovoj korisnosti za epidemiološka ispitivanja krvožilnih i 
metaboličkih poremećaja povezanih s izloženosti uranu. Na temelju zdravstvenih kartona 394 radnika koji 
su dio većeg kohortnog ispitivanja s 2897 radnika u francuskim nuklearnim elektranama stvorena je 
elektronička baza podataka s informacijama o ranijem zaposlenju, položaju, opisu posla, liječničkim 
pregledima i krvnim nalazima. Baza obuhvaća podatke iz 9.471 liječničkog pregleda te 12.735 krvnih 
nalaza. Dostupnost i potpunost podataka za gotovo sve parametre važne za procjenu rizika od bolesti srca 
i krvožilja bile su više od 90 %, ali neujednačene, i popravljale su se tek prema kraju 50-godišnjeg praćenja. 
U nedostatku biobanaka, prikupljanje i digitalizacija pouzdanih arhivskih podataka iz medicine rada 
vrijedan su alternativni izvor za epidemiološka i etiološka ispitivanja. Biobanke rijetko čuvaju biološke 
uzorke radnika cijeli njegov radni vijek, pa zdravstveni podaci čuvani u arhivima nuklearnih elektrana 
mogu kvalitetno dopuniti prazninu uslijed nedostatka biomarkera i dati uvid u nastanak i razvoj bolesti 
metabolizma te srca i krvožilja.
KLJUČNE RIJEČI: bolesti srca i krvožilja; epidemiologija; etiologija; ionizirajuće zračenje; medicina 
rada; smrtnost
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